Buy & Sell State Street SPDR S&P Biotech ETF (XBI) – State Street SPDR S&P Biotech ETF Price Today
Key Stats
- -Market Cap
- Broad Market / FactorSector
- -9.72%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 11 daysTypical Hold Time
State Street SPDR S&P Biotech ETF (XBI) is currently valued at a market capitalization of -, with an enterprise value of -. Over the past 52 weeks, State Street SPDR S&P Biotech ETF has traded between a low of $69.8 and a high of $132.88, highlighting its annual price range. Over the past three months, State Street SPDR S&P Biotech ETF has recorded a drawdown of -9.72%, reflecting recent price volatility. State Street SPDR S&P Biotech ETF offers a dividend yield of -. On average, investors hold State Street SPDR S&P Biotech ETF for approximately 11 days, indicating typical investor behavior on the platform.
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
